C. Difficile and Ursodiol
A Clinical Trial for the Off Label Use of Ursodiol for the Prevention of Recurrent C. Difficile Colitis and Diarrhea
Sponsor: NYU Langone Health
A PHASE4 clinical study on Diarrhea, this trial is completed. The trial is conducted by NYU Langone Health and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Mar 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Aug 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting · Phase: NA → PHASE4
-
Feb 2017 — May 2017 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .